廣汽埃安航跡自動駕駛項目計劃落地廣州知識城
廣州黃埔舉行投資促進大會,兩批共計43個重點項目集中籤約,投資總額約516億元人民幣(下同),預計產值營業收入約954億元人民幣。
此次簽約項目涉及新一代信息技術、生物製造、汽車行業、人工智能與智能裝備、低空經濟等多個產業。其中,視源全球總部基地、廣汽(02238.HK)(601238.SH)旗下廣汽埃安航跡自動駕駛、卡沃無人機等單個項目投資超過10億元。
埃安航跡自動駕駛項目計劃落地廣州知識城。該項目由廣汽埃安新能源汽車與自動駕駛領域獨角獸公司北京航跡科技合作投資。項目主要從事自動駕駛車輛的產品定義、研發、測試及銷售等。(ta/w) ~
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.